Tresiba® is a once-daily, long-acting insulin indicated to improve glycemic control in patients 1 year of age and older with diabetes mellitus.1 Tresiba® comes in 3 administration options: Tresiba® FlexTouch® U-100, Tresiba® FlexTouch® U-200, and a U-100 multiple-dose, 10-mL vial.1
Filling Tresiba® prescriptions: What you need to know

Concentration
100 units/mL
Pens per package
5
Volume per pen
3 mL
Units of insulin per pen
300 units
Units of insulin per package
1500 units
Max dose per injection
80 units
Dose increment
1 unit
NDC number
0169-2660-15
Don’t forget to order NovoFine® Plus disposable needles. The 32G, 4-mm pen needle is Novo Nordisk's shortest and thinnest needle available.a
aNeedles are sold separately and may require a prescription in some states.

Concentration
200 units/mL
Pens per package
3
Volume per pen
3 mL
Units of insulin per pen
600 units
Units of insulin per package
1800 units
Max dose per injection
160 units
Dose increment
2 units
NDC number
0169-2550-13
Don’t forget to order NovoFine® Plus disposable needles. The 32G, 4-mm pen needle is Novo Nordisk's shortest and thinnest needle available.a
aNeedles are sold separately and may require a prescription in some states.

Concentration
100 units/mL
Vials per package
1 vial
Volume per vial
10 mL
Units of insulin per vial
1000 units
NDC number
0169-2662-11
An option for patients who prefer vials or children who require fewer than 5 units a day.
Click below to see more information about each administration option.
Eligible patients pay as little as $5 per 30-day supplyb
bFor up to 24 months. Maximum savings of $150 per 30-day supply. Eligibility and other restrictions apply.
Other facts about Tresiba®1:
Injected subcutaneously once daily, and for adults, at any time of day
- Instruct adult patients who miss a dose of Tresiba® to inject their daily dose during waking hours upon discovering the missed dose, then continue with their regular dosing schedule
- Tresiba® must be dosed at the same time each day for pediatric patients. Instruct pediatric patients who miss a dose of Tresiba® to contact their health care provider for guidance and to monitor blood glucose levels more frequently until the next scheduled dose
- Instruct adult patients to ensure that at least 8 hours have elapsed between consecutive Tresiba® injections
The recommended time between dose increases is 3 to 4 days
- No dose conversion needed
Opened (in-use) Tresiba® can be kept at room temperature (below 86°F), away from direct heat and light, or refrigerated (36°F to 46°F) for 56 days (8 weeks)
- The dose window for the Tresiba® FlexTouch® U-100 and U-200 pens shows the number of units to be delivered
- The vial offers an option for patients who prefer vials or children who require fewer than 5 units a day

Give your patients a game plan with the Diabetes Health Coach


Live calls from a Certified Diabetes Educator for the first 90 days of therapy for patients with diabetes starting Tresiba®, available in both English and Spanish.c

Personalized online coaching sessions on more than 25 topics—developed by leading diabetes experts.

Ongoing support that includes tools, education, interactive trackers, and diabetes-friendly recipes.

Encourage patients taking Tresiba® to register for personalized support.
cPatients with diabetes qualify for live phone support if they have been taking Tresiba® for less than 6 months and requested calls when registering for Cornerstones4Care®.